{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:26:26Z","timestamp":1790483186259,"version":"4.1.0"},"reference-count":337,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijbiomac.2023.125114","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:02:59Z","timestamp":1685498579000},"page":"125114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"P3","title":["Oral insulin delivery: Barriers, strategies, and formulation approaches: A comprehensive review"],"prefix":"10.1016","volume":"242","author":[{"given":"S.","family":"Spoorthi Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Halagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M. Asha","family":"Spandana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.V.","family":"Gangadharappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.125114_bb0005","author":"Wild"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S2213-8587(20)30337-5","article-title":"Insulin\u2019s centenary: the birth of an idea","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0025","series-title":"Wilson and Gisvold\u2019s Textbook of Organic Medicinal and Pharmaceutical Chemistry","author":"Beale","year":"1991"},{"issue":"3789","key":"10.1016\/j.ijbiomac.2023.125114_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.157.3789.697","article-title":"Insulin biosynthesis: evidence for a precursor","volume":"157","author":"Steiner","year":"1967","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.bi.57.070188.000245","article-title":"Sequences, sequences, and sequences","volume":"57","author":"Sanger","year":"1988","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1211\/0022357023376","article-title":"On the stability of insulin delivered through a new glucose-responsive polymeric composite membrane","volume":"56","author":"Zhang","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0050","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI112467","article-title":"Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues","volume":"77","author":"Firth","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/diab.31.9.795","article-title":"Insulin resistance is a prominent feature of insulin-dependent diabetes","volume":"31","author":"DeFronzo","year":"1982","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0060","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/er.2006-0026","article-title":"The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications","volume":"28","author":"Dunning","year":"2007","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0070","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF00400638","article-title":"Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM","volume":"38","author":"Vaag","year":"1995","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb0075","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2337\/diabetes.50.8.1872","article-title":"Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism","volume":"50","author":"Edgerton","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI27073","article-title":"Insulin\u2019s direct effects on the liver dominate the control of hepatic glucose production","volume":"116","author":"Edgerton","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0085","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/diabetes.50.6.1351","article-title":"Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity","volume":"50","author":"Basu","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0095","series-title":"Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics","article-title":"Oral hypoglycemic agents and the pharmacology of the endocrine pancreas","author":"Khan","year":"1991"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.10.1.1","article-title":"Diabetes control and complications trial (DCCT): results of feasibility study. The DCCT research group","volume":"10","author":"Crofford","year":"1987","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0110","unstructured":"N. T. S. et al., \u201cGlobal Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030\u201d."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1011948703571","article-title":"The influence of intestinal mucus components on the diffusion of drugs","volume":"15","author":"Larhed","year":"1998","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0169-409X(93)90010-2","article-title":"The effect of gastro-intestinal mucus on drug absorption","volume":"11","author":"MacAdam","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0130","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0135","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.addr.2005.07.002","article-title":"Thiomers: a new generation of mucoadhesive polymers","volume":"57","author":"Bernkop-Schn\u00fcrch","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2016.01.022","article-title":"Insulin loaded mucus permeating nanoparticles: addressing the surface characteristics as feature to improve mucus permeation","volume":"500","author":"Pereira De Sousa","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus\u2606","volume":"124","author":"Huckaby","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \u2018mucus-inert\u2019 agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0016-5085(70)80092-0","article-title":"Surface structure of intestinal epithelium","volume":"58","author":"Balcerzak","year":"1970","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/aja.1001410403","article-title":"Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell","volume":"141","author":"Cheng","year":"1974","journal-title":"Am. J. Anat."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/gut.6.3.225","article-title":"Number, size, and distribution of Peyer\u2019s patches in the human small intestine: part I the development of Peyer\u2019s patches","volume":"6","author":"Cornes","year":"1965","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0170","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus PEYER\u2019S-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2023.125114_bb0175","article-title":"A validated RP-HPLC method for the determination of recombinant human insulin in bulk and pharmaceutical dosage form","volume":"7","author":"Moussa","year":"2010","journal-title":"E-J. Chemistry"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0928-0987(97)10019-7","article-title":"Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs\u2019 lipophilicity and molecular weight","volume":"6","author":"Camenisch","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19\u201320","key":"10.1016\/j.ijbiomac.2023.125114_bb0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.14.15","article-title":"Formulation strategies to improve oral peptide delivery","volume":"3","author":"Maher","year":"2014","journal-title":"Pharm. Pat. Anal."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.addr.2011.12.014","article-title":"Oral biodrug delivery using cell-penetrating peptide","volume":"64","author":"Khafagy","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2004.02.018","article-title":"Chances and pitfalls of cell penetrating peptides for cellular drug delivery","volume":"58","author":"Tr\u00e9hin","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5\u20136 SPECL.ISSUE","key":"10.1016\/j.ijbiomac.2023.125114_bb0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10867-008-9074-3","article-title":"Cell penetrating peptides: how do they do it?","volume":"33","author":"Herce","year":"2007","journal-title":"J. Biol. Phys."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb0220","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0225","first-page":"76","article-title":"Current status of the Oral delivery of insulin","volume":"25","author":"Agarwal","year":"2001","journal-title":"Pharm. Technol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0235","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0240","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1172\/JCI113987","article-title":"Loosening tight junctions. Lessons from the intestine","volume":"83","author":"Madara","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0250","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/gut.6.3.225","article-title":"Number, size, and distribution of Peyer\u2019s patches in the human small intestine: part I the development of Peyer\u2019s patches","volume":"6","author":"Cornes","year":"1965","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0260","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus PEYER\u2019S-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/02652048.2012.742159","article-title":"Microencapsulation techniques to develop formulations of insulin for oral delivery: a review","volume":"30","author":"C\u00e1rdenas-Bail\u00f3n","year":"2013","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs: barriers and developments","volume":"19","author":"Hamman","year":"2005","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0275","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1177\/193229680900300627","article-title":"Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation","volume":"3","author":"Geho","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0280","author":"Blair"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0285","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","article-title":"Solid lipid nanoparticles as a drug delivery system for peptides and proteins","volume":"59","author":"Almeida","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0927-7765(02)00053-X","article-title":"Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules","volume":"27","author":"Garc\u00eda-Fuentes","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0300","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/17425247.2016.1218462","article-title":"From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)","volume":"14","author":"Rehman","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0305","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/cr000700m","article-title":"Peroral route: an opportunity for protein and peptide drug delivery","volume":"101","author":"Sood","year":"2001","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.14.15","article-title":"Formulation strategies to improve oral peptide delivery","volume":"3","author":"Maher","year":"2014","journal-title":"Pharm. Pat. Anal."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0315","doi-asserted-by":"crossref","DOI":"10.1208\/pt030433","article-title":"In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III","volume":"3","author":"Li","year":"2002","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0320","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2005.09.028","article-title":"Effects of absorption promoters on insulin absorption through colon-targeted delivery","volume":"307","author":"Katsuma","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0325","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/17425247.2012.737779","article-title":"Novel non-invasive methods of insulin delivery","volume":"9","author":"Soares","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2009.01146.x","article-title":"The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes","volume":"12","author":"Luzio","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0335","series-title":"Methods and compositions for oral administration of proteins","author":"Kidron","year":"2009"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(96)01586-6","article-title":"The challenge of proteolytic enzymes in intestinal peptide delivery","volume":"46","author":"Langguth","year":"1997","journal-title":"J. Control. Release"},{"issue":"7507","key":"10.1016\/j.ijbiomac.2023.125114_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature13297","article-title":"Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones","volume":"511","author":"Maianti","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0350","first-page":"75","article-title":"Current status of the oral delivery of insulin","volume":"25","author":"Agarwal","year":"2001","journal-title":"Pharm. Technol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0355","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats","volume":"11","author":"Yamamoto","year":"1994","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0360","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1211\/146080800128735935","article-title":"Oral delivery of proteins: effect of chicken and duck ovomucoid on the stability of insulin in the presence of \u03b1-chymotrypsin and trypsin","volume":"6","author":"Agarwal","year":"2000","journal-title":"Pharm. Pharmacol. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0365","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharm. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0370","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0375","first-page":"75","article-title":"Current status of the oral delivery of insulin","volume":"25","author":"Agarwal","year":"2001","journal-title":"Pharm. Technol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0380","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2005.06.020","article-title":"Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol\u2013resin complex","volume":"302","author":"Halder","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125114_bb0385","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.3390\/molecules14072602","article-title":"Polymeric plant-derived excipients in drug delivery","volume":"14","author":"Beneke","year":"2009","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0390","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbm.a.32490","article-title":"Starch-based polymeric carriers for oral-insulin delivery","volume":"92","author":"Mahkam","year":"2010","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(01)00720-7","article-title":"Polysaccharides in colon-specific drug delivery","volume":"224","author":"Sinha","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/026520400405660","article-title":"Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats","volume":"17","author":"Ramadas","year":"2000","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109753","article-title":"Bioinspired oral insulin delivery system using yeast microcapsules","volume":"103","author":"Sabu","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125114_bb0410","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.progpolymsci.2009.04.001","article-title":"Chitin and chitosan polymers: chemistry, solubility and fiber formation","volume":"34","author":"Pillai","year":"2009","journal-title":"Prog. Polym. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0415","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1023\/A:1018967116988","article-title":"Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)","volume":"11","author":"Artursson","year":"1994","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0420","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/jps.24102","article-title":"In vivo evaluation of thiolated chitosan tablets for oral insulin delivery","volume":"103","author":"Millotti","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0425","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1469-8137.2004.00980.x","article-title":"Primary cell wall metabolism: tracking the careers of wall polymers in living plant cells","volume":"161","author":"Fry","year":"2004","journal-title":"New Phytol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0430","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2006.12.014","article-title":"Swelling and erosion of pectin matrix tablets and their impact on drug release behavior","volume":"67","author":"Sriamornsak","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0435","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.carbpol.2007.11.017","article-title":"On the gelling behaviour of \u2018nopal\u2019 (Opuntia ficus indica) low methoxyl pectin","volume":"73","author":"C\u00e1rdenas","year":"2008","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1640001","article-title":"Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats","volume":"164","author":"Musabayane","year":"2000","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0445","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-015-0136-y","article-title":"Nanoparticle based insulin delivery system: the next generation efficient therapy for type 1 diabetes","volume":"13","author":"Sharma","year":"2015","journal-title":"J. Nanobiotechnology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0450","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0455","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0460","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2010.04.006","article-title":"Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate\/chitosan nanoparticles","volume":"393","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2003.07.015","article-title":"Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin","volume":"277","author":"Mor\u00e7\u00f6l","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0475","article-title":"Novel nanoparticles for oral insulin delivery via the paracellular pathway","volume":"18","author":"Lin","year":"2007","journal-title":"Nanot"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0480","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.125114_bb0485","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/adfm.201001014","article-title":"Self-assembled pH-sensitive nanoparticles: a platform for Oral delivery of protein drugs","volume":"20","author":"Sonaje","year":"2010","journal-title":"Adv. Funct. Mater."},{"issue":"26","key":"10.1016\/j.ijbiomac.2023.125114_bb0490","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb0495","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0500","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.125114_bb0505","doi-asserted-by":"crossref","first-page":"1700413","DOI":"10.1002\/marc.201700413","article-title":"Advances in pH-sensitive polymers for Smart insulin delivery","volume":"38","author":"Xie","year":"2017","journal-title":"Macromol. Rapid Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.molpharmaceut.6b01029","article-title":"Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina","volume":"14","author":"Huang","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0515","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.matlet.2016.10.117","article-title":"Oral delivery of insulin using CaCO3-based composite nanocarriers with hyaluronic acid coatings","volume":"188","author":"Liu","year":"2017","journal-title":"Mater. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0520","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1208\/s12249-012-9807-2","article-title":"Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery","volume":"13","author":"Han","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0530","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1012096510125","article-title":"Development and in vitro evaluation of systems to protect peptide drugs from aminopeptidase N","volume":"14","author":"Bernkop-Schn\u00fcrch","year":"1997","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0535","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats","volume":"11","author":"Yamamoto","year":"1994","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0540","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00006676-198703000-00007","article-title":"Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats","volume":"2","author":"Otsuki","year":"1987","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0545","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0304-4165(76)90294-4","article-title":"Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor","volume":"421","author":"Melmed","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0550","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0016-5085(98)70205-7","article-title":"Adaptation of the human pancreas to inhibition of luminal proteolytic activity","volume":"115","author":"Friess","year":"1998","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb0555","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jbmr.1602","article-title":"A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the oral calcitonin in postmenopausal osteoporosis (ORACAL) trial","volume":"27","author":"Binkley","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0560","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/js9504604","article-title":"Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells","volume":"85","author":"Tomita","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0565","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2013.12.017","article-title":"The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition","volume":"86","author":"Welling","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0570","article-title":"pH-independent release of propranolol hydrochloride from HPMC-based matrices using organic acids","volume":"16","author":"Bolourchian","year":"2008"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0575","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1208\/s12249-013-0019-1","article-title":"The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices","volume":"14","author":"Dvo\u0159\u00e1\u010dkov\u00e1","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0580","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-5173(93)90195-L","article-title":"Cell-polarity dependent effect of chelation on the paracellular permeability of confluent caco-2 cell monolayers","volume":"90","author":"Noach","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0585","series-title":"In Vivo (Brooklyn)","article-title":"Anti-tumor activities of four chelating agents against human neuroblastoma cells","author":"Shen","year":"2005"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0590","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1023\/A:1016488623022","article-title":"Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo","volume":"13","author":"Lue\u00dfen","year":"1996","journal-title":"Pharm. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ijbiomac.2023.125114_bb0595","first-page":"95","article-title":"Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA","volume":"21","author":"Lanigan","year":"2002","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0600","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/BTER:76:2:133","article-title":"Effects of EDTA on trace elements and cardiovascular function in the anesthetised rabbit","volume":"76","author":"Ilb\u00e4ck","year":"2000","journal-title":"Biol. Trace Elem. Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.125114_bb0605","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.addr.2011.06.015","article-title":"Molecular origins of surfactant-mediated stabilization of protein drugs","volume":"63","author":"Lee","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0610","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/bk-1997-0675.ch012","article-title":"Surfactant-stabilized protein formulations: a review of protein-surfactant interactions and novel analytical methodologies","volume":"675","author":"Jones","year":"1997","journal-title":"ACS Symp. Ser."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0615","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1018990928259","article-title":"Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, alpha-chymotryptic degradation, and enteral absorption of insulin hexamers","volume":"10","author":"Shao","year":"1993","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0620","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport","volume":"549","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0625","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1208\/s12249-011-9647-5","article-title":"Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin","volume":"12","author":"Elsayed","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0630","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.xphs.2018.02.012","article-title":"Labrasol\u00ae and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae","volume":"107","author":"Heade","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb0635","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejps.2008.09.011","article-title":"Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate","volume":"36","author":"Sugibayashi","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0640","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.drudis.2021.01.020","article-title":"New perspectives in oral peptide delivery","volume":"26","author":"Zizzari","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0645","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0650","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1567201053586001","article-title":"Oral delivery of insulin with the eligen technology: mechanistic studies","volume":"2","author":"Malkov","year":"2005","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0655","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9610(98)00127-5","article-title":"Orally administered heparin for preventing deep venous thrombosis","volume":"176","author":"Gonze","year":"1998","journal-title":"Am. J. Surg."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0665","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2018.06.012","article-title":"Tissue acylcarnitine status in a mouse model of mitochondrial \u03b2-oxidation deficiency during metabolic decompensation due to influenza virus infection","volume":"125","author":"Tarasenko","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0670","unstructured":"\u201cRoom temperature stable oral calcitonin formulation,\u201d Aug. 2017."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb0675","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.3390\/molecules200814451","article-title":"Absorption-enhancing effects of bile salts","volume":"20","author":"Moghimipour","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030147","article-title":"Oral bioavailability and lymphatic transport of Pueraria flavone-loaded self-emulsifying drug-delivery systems containing sodium taurocholate in rats","volume":"10","author":"Qiao","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0685","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2005.05.016","article-title":"Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts","volume":"106","author":"Song","year":"2005","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0690","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0378-5173(90)90117-M","article-title":"Intestinal absorption enhancement by sodium taurodihydrofusidate of a peptide hormone analogue (dDAVP) and a macromolecule (BSA) in vitro and in vivo","volume":"59","author":"Lundin","year":"1990","journal-title":"Int. J. Pharm."},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2023.125114_bb0700","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0278-6915(99)00085-X","article-title":"Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives","volume":"37","author":"Williams","year":"1999","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb0705","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11095-007-9488-9","article-title":"Safe and effective permeation enhancers for oral drug delivery","volume":"25","author":"Whitehead","year":"2008","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0710","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acs.molpharmaceut.5b00803","article-title":"The pH of piperazine derivative solutions predicts their utility as transepithelial permeation enhancers","volume":"13","author":"Lamson","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0715","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s11095-017-2149-8","article-title":"Structure-function analysis of phenylpiperazine derivatives as intestinal permeation enhancers","volume":"34","author":"Fein","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0720","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2017.04.035","article-title":"ATRP-grown protein-polymer conjugates containing phenylpiperazine selectively enhance transepithelial protein transport","volume":"255","author":"Cummings","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0725","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/anatox\/35.1.54","article-title":"A drug toxicity death involving propylhexedrine and mitragynine","volume":"35","author":"Holler","year":"2011","journal-title":"J. Anal. Toxicol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.125114_bb0730","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/chin.201418283","article-title":"Toxicity of ionic liquids: eco(cyto)activity as complicated, but unavoidable parameter for task-specific optimization","volume":"45","author":"Egorova","year":"2014","journal-title":"ChemInform"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0735","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/acs.chemrev.6b00562","article-title":"Biological activity of ionic liquids and their application in pharmaceutics and medicine","volume":"117","author":"Egorova","year":"2017","journal-title":"Chem. Rev."},{"issue":"28","key":"10.1016\/j.ijbiomac.2023.125114_bb0740","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0745","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1039\/b922247b","article-title":"Novel biocompatible cholinium-based ionic liquids\u2014toxicity and biodegradability","volume":"12","author":"Petkovic","year":"2010","journal-title":"Green Chem."},{"issue":"28","key":"10.1016\/j.ijbiomac.2023.125114_bb0750","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.125114_bb0755","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1039\/C3CC48650H","article-title":"Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility","volume":"50","author":"Williams","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.125114_bb0760","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1039\/C8CS00325D","article-title":"The peculiar effect of water on ionic liquids and deep eutectic solvents","volume":"47","author":"Ma","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"MAR","key":"10.1016\/j.ijbiomac.2023.125114_bb0765","article-title":"Ionic liquid aqueous two-phase systems from a pharmaceutical perspective","volume":"7","author":"McQueen","year":"2019","journal-title":"Front. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0770","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","article-title":"Effects of PEG conjugation on insulin properties","volume":"54","author":"Hinds","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0775","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/152091502760306544","article-title":"Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2","volume":"4","author":"Clement","year":"2002","journal-title":"Diabetes Technol. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb0780","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1464-5491.2003.01076.x","article-title":"Alternative routes of insulin delivery","volume":"20","author":"Owens","year":"2003","journal-title":"Diabet. Med."},{"issue":"19\u201320","key":"10.1016\/j.ijbiomac.2023.125114_bb0785","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0790","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.2337\/diacare.27.12.2868","article-title":"Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects","volume":"27","author":"Wajcberg","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0795","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0800","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.14.15","article-title":"Formulation strategies to improve oral peptide delivery","volume":"3","author":"Maher","year":"2014","journal-title":"Pharm. Pat. Anal."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0805","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0810","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0815","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-5491.2004.01160.x","article-title":"A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects","volume":"21","author":"Kidron","year":"2004","journal-title":"Diabet. Med."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb0820","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(98)00037-4","article-title":"The effect of physical barriers and properties on the oral absorption of particulates","volume":"34","author":"Norris","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0830","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/js970124i","article-title":"Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin","volume":"86","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0835","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0939-6411(03)00191-7","article-title":"Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules","volume":"57","author":"Cournarie","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0840","unstructured":"P. S. Kumar, S. Ramakrishna, T. R. Saini, P. v Diwan, M. Satheesh, and K. Podaralla, \u201cInfluence of Microencapsulation Method and Peptide Loading on Formulation of Poly(Lactide-co-Glycolide) Insulin Nanoparticles\u201d."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0845","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb0850","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/js970124i","article-title":"Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin","volume":"86","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0855","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/jps.1113","article-title":"Production of insulin-loaded poly(ethylene glycol)\/poly(l-lactide) (PEG\/PLA) nanoparticles by gas antisolvent techniques","volume":"90","author":"Elvassore","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0860","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1081\/DDC-200047802","article-title":"Formulation of insulin-loaded polymeric nanoparticles using response surface methodology","volume":"31","author":"Attivi","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0865","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0870","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2003.10.015","article-title":"Effective protein release from PEG\/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques","volume":"94","author":"Caliceti","year":"2004","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0875","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(03)00055-3","article-title":"Insulin containing polyethylenimine-dextran sulfate nanoparticles","volume":"255","author":"Tiyaboonchai","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0880","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0885","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.10149","article-title":"Formulation pH modulates the interaction of insulin with chitosan nanoparticles","volume":"91","author":"Zengshuan","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0890","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0895","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2004.10.003","article-title":"Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles","volume":"288","author":"Mesiha","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0900","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0905","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2003.10.015","article-title":"Effective protein release from PEG\/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques","volume":"94","author":"Caliceti","year":"2004","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb0910","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1081\/DDC-120030930","article-title":"Insulin-loaded calcium pectinate nanoparticles: effects of pectin molecular weight and formulation pH","volume":"30","author":"Cheng","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0915","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.05.015","article-title":"Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles","volume":"342","author":"Jintapattanakit","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0920","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"de Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0925","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0939-6411(00)00084-9","article-title":"Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?","volume":"50","author":"Jung","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0930","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0935","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/bm060065f","article-title":"Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization","volume":"7","author":"Qian","year":"2006","journal-title":"Biomacromolecules"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0940","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0945","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb0950","first-page":"1029","article-title":"Oil-in-water nanoemulsions comprising Berberine in olive oil: biological activities, binding mechanisms to human serum albumin or holo-transferrin and QMMD simulations","volume":"39","author":"Sharifi-Rad","year":"2020"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb0955","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/biom10101366","article-title":"Human serum albumin binds native insulin and aggregable insulin fragments and inhibits their aggregation","volume":"10","author":"Wasko","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb0960","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1021\/acsomega.1c06119","article-title":"Synthesis and evaluation of the insulin-albumin conjugate with prolonged glycemic control","volume":"7","author":"Rao","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0965","author":"Zare-Feizabadi"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.119042","article-title":"Novel perspective into the interaction behavior study of the cyanidin with human serum albumin-holo transferrin complex: spectroscopic, calorimetric and molecular modeling approaches","volume":"356","author":"Khashkhashi-Moghadam","year":"2022","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0975","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/bio.4173","article-title":"Evaluation of the binding effect and cytotoxicity assay of 2-Ethyl-5-(4-methylphenyl) pyramido pyrazole ophthalazine trione on calf thymus DNA: spectroscopic, calorimetric, and molecular dynamics approaches","volume":"37","author":"Marjani","year":"2022","journal-title":"Luminescence"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb0980","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpb.2006.09.005","article-title":"Probing insulin\u2019s secondary structure after entrapment into alginate\/chitosan nanoparticles","volume":"65","author":"Sarmento","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb0985","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2006.12.007","article-title":"Nanoparticulate delivery system for insulin: design, characterization and in vitro\/in vivo bioactivity","volume":"30","author":"Reis","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb0990","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0939-6411(03)00191-7","article-title":"Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules","volume":"57","author":"Cournarie","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb0995","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1000","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1081\/DDC-120030930","article-title":"Insulin-loaded calcium pectinate nanoparticles: effects of pectin molecular weight and formulation pH","volume":"30","author":"Cheng","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb1005","first-page":"209","article-title":"Oral delivery of insulin for treatment of diabetes: classical challenges and current opportunities","volume":"15","author":"Ansari","year":"2015","journal-title":"J. Med. Sci. (Faisalabad)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0169-409X(91)90013-3","article-title":"(B) Mechanisms of peptide and protein absorption: (1) Paracellular intestinal transport: modulation of absorption","volume":"7","author":"Nellans","year":"1991","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6 Pt 3","key":"10.1016\/j.ijbiomac.2023.125114_bb1015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","article-title":"Polymer-based nanoparticles for oral insulin delivery: revisited approaches","volume":"33","author":"Fonte","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"01","key":"10.1016\/j.ijbiomac.2023.125114_bb1020","article-title":"Oral nano-insulin therapy: current progress on nanoparticle-based devices for intestinal epithelium-targeted insulin delivery","volume":"s4","author":"Ahmad","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb1025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2217\/nnm.16.43","article-title":"Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes","volume":"11","author":"Kaklotar","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4314\/tjpr.v13i1.1","article-title":"Development and optimization of insulin-chitosan nanoparticles","volume":"13","author":"Zhao","year":"2014","journal-title":"Trop. J. Pharm. Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb1035","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.progpolymsci.2012.04.004","article-title":"Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review","volume":"37","author":"Mukhopadhyay","year":"2012","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1040","first-page":"2127","article-title":"Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery","volume":"9","author":"Song","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2006.02.031","article-title":"Preparation and characterization of mucoadhesive polymer-coated nanoparticles","volume":"316","author":"Cui","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb1050","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/18\/10\/105102","article-title":"Novel nanoparticles for oral insulin delivery via the paracellular pathway","volume":"18","author":"Lin","year":"2007","journal-title":"Nanotechnology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb1055","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/18\/10\/105102","article-title":"Novel nanoparticles for oral insulin delivery via the paracellular pathway","volume":"18","author":"Lin","year":"2007","journal-title":"Nanotechnology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","article-title":"Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin","volume":"232","author":"Lopes","year":"2016","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb1070","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/jps.21347","article-title":"Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response","volume":"97","author":"Reis","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.125114_bb1075","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2217\/nnm-2017-0019","article-title":"Using dextran-encapsulated gold nanoparticles as insulin carriers to prolong insulin activity","volume":"12","author":"Lee","year":"2017","journal-title":"Nanomedicine (Lond)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb1080","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/gels8060358","article-title":"The effect of deoxycholic acid on chitosan-enabled matrices for tissue scaffolding and injectable nanogels","volume":"8","author":"Kovacevic","year":"2022","journal-title":"Gels"},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb1090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2005.09.040","article-title":"Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier","volume":"109","author":"Chae","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1095","first-page":"85","article-title":"Chitosan and its derivatives as self-assembled systems for drug delivery","year":"2015","journal-title":"Controlled Drug Deliv."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb1100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/10837450.2021.1966036","article-title":"pH-sensitive chitosan-deoxycholic acid\/alginate nanoparticles for oral insulin delivery","volume":"26","author":"Zhang","year":"2021","journal-title":"Pharm. Dev. Technol."},{"issue":"56B","key":"10.1016\/j.ijbiomac.2023.125114_bb1105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.9734\/jpri\/2021\/v33i56B33956","article-title":"Stability of insulin on polycaprolactone nanoparticles as a function of surface properties","volume":"33","author":"Namazi","year":"2021","journal-title":"J. Pharm. Res. Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/17425247.5.1.45","article-title":"Nanoparticle strategies for the oral delivery of insulin","volume":"5","author":"Damg\u00e9","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/02652048.2019.1604846","article-title":"Self-assembly pH-sensitive chitosan\/alginate coated polyelectrolyte complexes for oral delivery of insulin","volume":"36","author":"Chen","year":"2019","journal-title":"J. Microencapsul."},{"issue":"48","key":"10.1016\/j.ijbiomac.2023.125114_bb1120","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1039\/C4TB01374C","article-title":"Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo","volume":"2","author":"Yang","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J. Control. Release"},{"issue":"28","key":"10.1016\/j.ijbiomac.2023.125114_bb1130","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb1135","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/js970124i","article-title":"Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin","volume":"86","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2008.12.017","article-title":"Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation","volume":"37","author":"Graf","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1145","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb1150","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsami.8b00507","article-title":"Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/03639045.2010.497151","article-title":"The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process","volume":"37","author":"Yang","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb1165","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"issue":"213","key":"10.1016\/j.ijbiomac.2023.125114_bb1170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007049","article-title":"Transepithelial transport of fc-targeted nanoparticles by the neonatal fc receptor for oral delivery","volume":"5","author":"Pridgen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2013.11.028","article-title":"Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study","volume":"460","author":"Niu","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2011.03.031","article-title":"Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes","volume":"152","author":"Schlegel","year":"2011","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1507\/endocrj1954.28.235","article-title":"No reduction of blood glucose in diabetic rats after oral administration of insulin liposomes prepared under acidic conditions","volume":"28","author":"Kawada","year":"1981","journal-title":"Endocrinol. Jpn."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/026520400405660","article-title":"Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats","volume":"17","author":"Ramadas","year":"2000","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1195","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0005-2760(80)90131-9","article-title":"The stability of liposomes in vitro to pH, bile salts and pancreatic lipase","volume":"620","author":"Rowland","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.125114_bb1200","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.lfs.2004.05.027","article-title":"The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer","volume":"75","author":"Degim","year":"2004","journal-title":"Life Sci."},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2023.125114_bb1205","first-page":"2945","article-title":"Oral administration of liposomal insulin","volume":"6","author":"Tde\u01e7im","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2009.08.013","article-title":"Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect","volume":"382","author":"Hanato","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(97)00237-8","article-title":"Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract","volume":"157","author":"Iwanaga","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1023\/A:1016009313548","article-title":"Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes","volume":"13","author":"Takeuchi","year":"1996","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2018.04.020","article-title":"Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome","volume":"544","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2017.05.032","article-title":"Polymer coated mucoadhesive liposomes intended for the management of xerostomia","volume":"527","author":"Adamczak","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2016.11.028","article-title":"Polysaccharide-coated liposomal formulations for dental targeting","volume":"516","author":"Pistone","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2015.12.030","article-title":"An in vitro study of mucoadhesion and biocompatibility of polymer coated liposomes on HT29-MTX mucus-producing cells","volume":"498","author":"Adamczak","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb1245","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/jphp.12448","article-title":"The studies of N-Octyl-N-arginine-chitosan coated liposome as an oral delivery system of cyclosporine a","volume":"67","author":"Deng","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.03.061","article-title":"Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins","volume":"392","author":"Mohanraj","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1255","article-title":"B12-functionalized PEGylated liposomes for the oral delivery of insulin: in vitro and in vivo studies","volume":"69","author":"Sarhadi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1265","article-title":"Molecular mechanism of the intestinal biotin transport process","volume":"277","author":"Chatterjee","year":"1999","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2013.07.011","article-title":"Biotinylated liposomes as potential carriers for the oral delivery of insulin","volume":"10","author":"Zhang","year":"2014","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1275","first-page":"1","article-title":"Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity","volume":"9","author":"Zhang","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1280","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","article-title":"Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration","volume":"15","author":"Agrawal","year":"2014","journal-title":"Biomacromolecules"},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb1285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0169-409X(00)00070-3","article-title":"Lectin-mediated mucosal delivery of drugs and microparticles","volume":"43","author":"Clark","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(01)00650-0","article-title":"The interaction between wheat germ agglutinin and other plant lectins with prostate cancer cells Du-145","volume":"221","author":"Gabor","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125114_bb1295","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1023\/A:1011926026653","article-title":"Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells","volume":"15","author":"Wirth","year":"1998","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jps.10507","article-title":"Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells","volume":"93","author":"Mo","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2009.10.027","article-title":"M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes","volume":"385","author":"Shukla","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125114_bb1310","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1359-6446(01)02010-4","article-title":"Bilosomes: the answer to oral vaccine delivery?","volume":"6","author":"Senior","year":"2001","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb1315","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2174\/1381612823666170124111142","article-title":"Bile salt stabilized vesicles (Bilosomes): a novel Nano-Pharmaceutical Design for Oral Delivery of proteins and peptides","volume":"23","author":"Ahmad","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1320","first-page":"1847","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","volume":"23","author":"Aburahma","year":"2016","journal-title":"Drug Deliv."},{"issue":"0","key":"10.1016\/j.ijbiomac.2023.125114_bb1325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18433\/J3CK88","article-title":"Nanosized liposomes containing bile salt: a vesicular nanocarrier for enhancing oral bioavailability of BCS class III drug","volume":"20","author":"Arafat","year":"2017","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1330","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.drudis.2016.03.013","article-title":"Bilosomes in the context of oral immunization: development, challenges and opportunities","volume":"21","author":"Shukla","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.07.041","article-title":"Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus","volume":"549","author":"Wong","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118772","article-title":"Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235)","volume":"573","author":"Visetvichaporn","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/964051","article-title":"Self-microemulsifying drug delivery systems: an attractive strategy for enhanced therapeutic profile","volume":"2014","author":"Akula","year":"2014","journal-title":"Int. Sch. Res. Notices"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1350","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1080\/10717544.2022.2118399","article-title":"Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design","volume":"29","author":"Goo","year":"2022","journal-title":"Drug Deliv."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb1355","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/03639040500216428","article-title":"Preparation and evaluation of SEDDS and SMEDDS containing carvedilol","volume":"31","author":"Wei","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb1360","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1002\/jps.23757","article-title":"Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems","volume":"102","author":"Friedl","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1365","unstructured":"H. Rachmawati, D. H. Rasaputri, R. A. Susilowidodo, S. T. Darijanto, and Y. C. Sumirtapura, \u201cThe Influence of Oils and Surfactants on the Formation of Self-Nanoemulsifying Drug Delivery Systems (Snedds) Containing Therapeutic Protein\u201d."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125114_bb1370","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3109\/10717544.2015.1020119","article-title":"Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus","volume":"23","author":"Ding","year":"2016","journal-title":"Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2017.02.019","article-title":"Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems","volume":"520","author":"Griesser","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","article-title":"SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs","volume":"142","author":"Mahmood","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125114_bb1385","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.xphs.2016.01.006","article-title":"Impact of lipid-based drug delivery systems on the transport and uptake of insulin across Caco-2 cell monolayers","volume":"105","author":"Li","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1640001","article-title":"Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats","volume":"164","author":"Musabayane","year":"2000","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1081\/DDC-120030930","article-title":"Insulin-loaded calcium pectinate nanoparticles: effects of pectin molecular weight and formulation pH","volume":"30","author":"Cheng","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1400","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.biomaterials.2006.11.008","article-title":"Superporous hydrogels containing poly(acrylic acid-co-acrylamide)\/O-carboxymethyl chitosan interpenetrating polymer networks","volume":"28","author":"Yin","year":"2007","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1405","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0168-3659(99)00006-1","article-title":"Modulating insulin-release profile from pH\/thermosensitive polymeric beads through polymer molecular weight","volume":"59","author":"Ramkissoon-Ganorkar","year":"1999","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1410","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/0250-474X.36932","article-title":"Pulsatile Drug Delivery Systems","volume":"69","author":"Lalwani","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1415","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(01)00447-3","article-title":"Modulated insulin delivery from glucose-sensitive hydrogel dosage forms","volume":"77","author":"Kim","year":"2001","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1420","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/acs.molpharmaceut.6b00875","article-title":"Salecan-based pH-sensitive hydrogels for insulin delivery","volume":"14","author":"Qi","year":"2017","journal-title":"Mol. Pharm."},{"issue":"40","key":"10.1016\/j.ijbiomac.2023.125114_bb1425","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1021\/acs.jafc.8b02879","article-title":"Oral Administration of Salecan-Based Hydrogels for controlled insulin delivery","volume":"66","author":"Qi","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1430","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijbiomac.2020.06.283","article-title":"Facile fabrication of functional hydrogels consisting of pullulan and polydopamine fibers for drug delivery","volume":"163","author":"Su","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1435","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbm.a.31674","article-title":"Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs","volume":"86","author":"Daoud-Mahammed","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijpharm.2010.01.021","article-title":"Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin","volume":"389","author":"Hamishehkar","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1445","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ejpb.2008.07.015","article-title":"Quality by design - spray drying of insulin intended for inhalation","volume":"70","author":"Maltesen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1450","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2008.10.020","article-title":"Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117","volume":"366","author":"Qian","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb1455","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/polym7050836","article-title":"Addition of zinc improves the physical stability of insulin in the primary emulsification step of the poly(lactide-co-glycolide) microsphere preparation process","volume":"7","author":"Manoharan","year":"2015","journal-title":"Polymers"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1460","first-page":"1","article-title":"Ordered mesoporous materials for drug delivery","volume":"117","author":"Wang","year":"2009","journal-title":"Microporous Mesoporous Mater."},{"issue":"111","key":"10.1016\/j.ijbiomac.2023.125114_bb1465","doi-asserted-by":"crossref","first-page":"91686","DOI":"10.1039\/C5RA17780D","article-title":"The role of SBA-15 in drug delivery","volume":"5","author":"Fathi Vavsari","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1470","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4028\/www.scientific.net\/AMR.829.251","article-title":"Preparation of mesoporous silica nanoparticles for insulin drug delivery","volume":"829","author":"Siavashani","year":"2014","journal-title":"Adv. Mater. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1475","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4103\/0250-474X.59540","article-title":"Porous carriers for controlled\/modulated drug delivery","volume":"71","author":"Ahuja","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1480","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2009.11.012","article-title":"Release profile of insulin entrapped on mesoporous materials by freeze\u2013thaw method","volume":"386","author":"Tozuka","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1485","article-title":"Low pressure mediated enhancement of nanoparticle and macromolecule loading into porous silicon structures","volume":"1","author":"Leonard","year":"2014","journal-title":"Mesoporous Biomater"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125114_bb1490","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.progpolymsci.2012.04.004","article-title":"Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review","volume":"37","author":"Mukhopadhyay","year":"2012","journal-title":"Prog. Polym. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4314\/jpb.v12i1.1","article-title":"Effect of mucin extraction method on some properties of metronidazole mucoadhesive loaded patches","volume":"12","author":"Arhewoh","year":"2015","journal-title":"J. Pharm. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1505","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/acs.nanolett.6b04523","article-title":"Yeast microcapsule-mediated targeted delivery of diverse nanoparticles for imaging and therapy via the Oral route","volume":"17","author":"Zhou","year":"2017","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.mattod.2017.05.006","article-title":"Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease","volume":"20","author":"Zhang","year":"2017","journal-title":"Mater. Today"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1515","first-page":"5865","article-title":"Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification\/internal gelation","volume":"10","author":"Lopes","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109753","article-title":"Bioinspired oral insulin delivery system using yeast microcapsules","volume":"103","author":"Sabu","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1525","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2019.05.003","article-title":"Glucose-responsive complex micelles for self-regulated delivery of insulin with effective protection of insulin and enhanced hypoglycemic activity in vivo","volume":"180","author":"Wu","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125114_bb1530","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125114_bb1535","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addr.2013.04.006","article-title":"Oral delivery of proteins by biodegradable nanoparticles","volume":"65","author":"Bakhru","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1540","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1545","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","article-title":"Nanoparticle uptake by the oral route: fulfilling its potential?","volume":"2","author":"Florence","year":"2005","journal-title":"Drug Discov. Today Technol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1550","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2012.03.022","article-title":"\u2018Targeting\u2019 nanoparticles: the constraints of physical laws and physical barriers","volume":"164","author":"Florence","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125114_bb1555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","article-title":"Oral delivery of macromolecules using intestinal patches: applications for insulin delivery","volume":"98","author":"Whitehead","year":"2004","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.125114_bb1560","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1359-6446(05)03489-6","article-title":"Gastrointestinal patch systems for oral drug delivery","volume":"10","author":"Tao","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1565","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","article-title":"Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats","volume":"95","author":"Krauland","year":"2004","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1570","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/jphp.12694","article-title":"In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor","volume":"69","author":"Wong","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1575","doi-asserted-by":"crossref","DOI":"10.1208\/pt030433","article-title":"In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODESTM) in multi-pH media using United States Pharmacopeia apparatus II and III","volume":"3","author":"Li","year":"2002","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00004-2","article-title":"Colon-specific drug delivery: new approaches and in vitro\/in vivo evaluation","volume":"235","author":"Yang","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1585","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2005.09.028","article-title":"Effects of absorption promoters on insulin absorption through colon-targeted delivery","volume":"307","author":"Katsuma","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"4517","key":"10.1016\/j.ijbiomac.2023.125114_bb1590","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.7280691","article-title":"Sulfhydryl compounds may mediate gastric cytoprotection","volume":"214","author":"Szabo","year":"1981","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2023.125114_bb1595","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125114_bb1600","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jps.2600750511","article-title":"Effects of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption","volume":"75","author":"Kajii","year":"1986","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125114_bb1605","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.2042-7158.1988.tb05279.x","article-title":"The effects of salicylate concentration on the uptake of salicylate and cefmetazole into rat isolated small intestinal epithelial cells","volume":"40","author":"Suzuka","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2023.125114_bb1610","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(02)00024-8","article-title":"Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs","volume":"237","author":"Hosny","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1615","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6865(97)00018-6","article-title":"Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate","volume":"72","author":"Hosny","year":"1997","journal-title":"Pharm. Acta Helv."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125114_bb1620","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.matt.2021.08.011","article-title":"Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes","volume":"4","author":"Xiao","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1625","series-title":"Processing and Scale-Up of Polymeric Nanoparticles","first-page":"433","author":"Vauthier","year":"2011"},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1635","doi-asserted-by":"crossref","unstructured":"P. Fonte et al., \u201cPolymer-based nanoparticles for oral insulin delivery: revisited approaches,\u201d Biotechnol. Adv., vol. 33, no. 6 Pt 3, pp. 1342\u20131354, Sep. 2015, doi: https:\/\/doi.org\/10.1016\/J.BIOTECHADV.2015.02.010.","DOI":"10.1016\/j.biotechadv.2015.02.010"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1640","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1932296814529988","article-title":"Oral insulin reloaded: a structured approach","volume":"8","author":"Zijlstra","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb1645","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4155\/TDE.15.47","article-title":"Why most oral insulin formulations do not reach clinical trials","volume":"6","author":"Lopes","year":"2015","journal-title":"Ther. Deliv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1650","article-title":"Oral insulin delivery: novel strategies","volume":"11","author":"Hirlekar","year":"2017","journal-title":"Asian J Pharm"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125114_bb1655","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharm J"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125114_bb1660","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1932296814529988","article-title":"Oral insulin reloaded: a structured approach","volume":"8","author":"Zijlstra","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1665","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1675","unstructured":"\u201cCA2518216A1 - Oral insulin therapies and protocol - Google Patents.\u201d https:\/\/patents.google.com\/patent\/CA2518216A1\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1680","unstructured":"\u201cEP1592438B1 - Night-time oral insulin therapy - Google Patents.\u201d https:\/\/patents.google.com\/patent\/EP1592438B1\/it (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1685","unstructured":"\u201cES2397061T3 - Procedures and compositions for oral insulin administration - Google Patents.\u201d https:\/\/patents.google.com\/patent\/ES2397061T3\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1690","unstructured":"\u201cCA2702892C - An orally administerable solid pharmaceutical composition and a process thereof - Google Patents.\u201d https:\/\/patents.google.com\/patent\/CA2702892C\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1695","unstructured":"\u201cES2546016T3 - Procedure for the preparation of insulin conjugates - Google Patents.\u201d https:\/\/patents.google.com\/patent\/ES2546016T3\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1700","unstructured":"\u201cUS9186412B2 - Methods and compositions for oral administration of insulin - Google Patents.\u201d https:\/\/patents.google.com\/patent\/US9186412B2\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1705","unstructured":"\u201cKR101755434B1 - Protease stabilized, acylated insulin analogues - Google Patents.\u201d https:\/\/patents.google.com\/patent\/KR101755434B1\/en (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1710","unstructured":"\u201cES2618073T3 - Insulin analogs stabilized against proteases - Google Patents.\u201d https:\/\/patents.google.com\/patent\/ES2618073T3\/en?oq=ES2618073T3+ (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1715","unstructured":"\u201cCN102123697B - Methods and compositions for oral administration of proteins - Google Patents.\u201d https:\/\/patents.google.com\/patent\/CN102123697B\/en?oq=CN102123697B (accessed Feb. 14, 2023)."},{"key":"10.1016\/j.ijbiomac.2023.125114_bb1720","unstructured":"\u201cJP7064226B2 - A composition containing a protease inhibitor, a composition containing the composition, and a method for producing and using the composition. - Google Patents.\u201d https:\/\/patents.google.com\/patent\/JP7064226B2\/en (accessed Feb. 14, 2023)."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125114_bb1725","first-page":"973","article-title":"Why most oral insulin formulations do not reach clinical trials","volume":"6","author":"Lopes","year":"2015"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125114_bb1730","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0976-0105.103822","article-title":"Review of insulin and its analogues in diabetes mellitus","volume":"3","author":"Mane","year":"2012","journal-title":"J. Basic Clin. Pharm."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023020081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023020081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:22:54Z","timestamp":1758882174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023020081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":337,"alternative-id":["S0141813023020081"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125114","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral insulin delivery: Barriers, strategies, and formulation approaches: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"125114"}}